Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial

Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T22:21:47.000Z thumbnail image
  4. Check
    31 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T09:45:37.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T07:34:27.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T22:08:18.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The intervention type has been updated to 'Verified 2022-09 by Innovent Biologics (Suzhou) Co. Ltd.' with the last known status as 'Recruiting', reflecting a revision from v2.13.3 to v2.14.0.
    Difference
    3%
    Check dated 2025-01-12T17:40:36.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:36:54.000Z thumbnail image

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.